LuciRip 50 mg Tablet
Request Pricing & Availability
Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.
Description
LuciRip 50 mg tablets contain ripretinib, a switch-control tyrosine kinase inhibitor of KIT and PDGFRA. It is used for advanced gastrointestinal stromal tumour (GIST) in adults who have already received three or more kinase inhibitors, including imatinib. LuciRip is a prescription-only medicine; treatment, dose and monitoring should be decided and supervised by the prescribing specialist. Strength: 50 mg per tablet. Pack: 90 Tablets. Manufacturer: Lucius Pharmaceuticals (Laos).
Related Products
-
Lenvitib 10 mg Capsule
LenvatinibPrice on request
Request pricing -
Lucimird 1 mg Capsule
Price on request
Request pricing -
Luciorfor 17.2 mg Tablet
Price on request
Request pricing -
Luciorfor 14.5 mg Tablet
Price on request
Request pricing -
Luciorfor 9 mg Tablet
Price on request
Request pricing -
Luciorfor 5.5 mg Tablet
Price on request
Request pricing -
Luciorfor 2.5 mg Tablet
Price on request
Request pricing -
Luciorfor 0.8 mg Tablet
Price on request
Request pricing -
LuciPemafib 0.1 mg Tablet
Price on request
Request pricing -
LuciVeric 10 mg Tablet
Price on request
Request pricing -
LuciLemb 5 mg Tablet
Price on request
Request pricing -
LuciElag 200 mg Tablet
Price on request
Request pricing
Shipping & Delivery
- Ships from
- India, worldwide delivery
- Order processing
- 1–3 business days after checks
- Transit time
- 5–7 business days by express courier
- Tracking
- Tracking number sent by email or SMS
- Packaging
- Discreet, tamper-evident, cold-chain available
- Duties & taxes
- Payable by the recipient on import
Only logged in customers who have purchased this product may leave a review.

Reviews
Clear filtersThere are no reviews yet.